Literature DB >> 25487311

CPAP washout prior to reevaluation polysomnography: a sleep surgeon's perspective.

Anneclaire V M T Vroegop1, Jim W Smithuis, Linda B L Benoist, Olivier M Vanderveken, Nico de Vries.   

Abstract

PURPOSE: Obstructive sleep apnea (OSA) is characterized by repetitive upper airway collapse during sleep, leading to decreased oxygen blood levels and arousal from sleep. The gold standard treatment option for moderate to severe OSA is considered continuous positive airway pressure (CPAP). In case primary treatment with CPAP fails, a reevaluation of disease severity [by means of the apnea/hypopnea-index (AHI)] can be required. A subset of patients that prefer a CPAP alternative is still using CPAP until the reevaluation polysomnography (PSG), and a so-called washout effect is not ruled out. The purpose of this study is to evaluate the evidence on the existence and duration of this washout effect and its clinical relevance for current practice.
METHODS: To identify papers for this review, an extensive literature search was run electronically through MEDLINE and EMBASE databases.
RESULTS: An overview of currently available literature on this washout effect and the findings of 13 studies on this topic are discussed.
CONCLUSION: There is some evidence that CPAP washout exists in patients with a stable BMI throughout the follow-up period. However, the intensity and duration of this effect remains unclear. Within the limitations of the present study, it seems reasonable to maintain a washout period of 1 week, in case alternative treatments options are considered and especially when a baseline PSG (and subsequent repeat PSG after treatment) is needed in case of clinical trials.

Entities:  

Mesh:

Year:  2014        PMID: 25487311     DOI: 10.1007/s11325-014-1086-6

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  36 in total

Review 1.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.

Authors: 
Journal:  Sleep       Date:  1999-08-01       Impact factor: 5.849

2.  Time course of changes in driving simulator performance with and without treatment in patients with sleep apnoea hypopnoea syndrome.

Authors:  P M Turkington; M Sircar; D Saralaya; M W Elliott
Journal:  Thorax       Date:  2004-01       Impact factor: 9.139

3.  [Sleep-related breathing disorders--a second edition of the International Classification of Sleep Disorders (ICSD-2) of the American Academy of Sleep Medicine (AASM)].

Authors:  H-W Duchna
Journal:  Pneumologie       Date:  2006-09

4.  Changes in snoring characteristics after 30 days of nasal continuous positive airway pressure in patients with non-apnoeic snoring: a controlled trial.

Authors:  F Sériès; I Marc
Journal:  Thorax       Date:  1994-06       Impact factor: 9.139

5.  Effect of chronic continuous positive airway pressure (CPAP) therapy on upper airway size in patients with sleep apnoea/hypopnoea syndrome.

Authors:  I L Mortimore; P Kochhar; N J Douglas
Journal:  Thorax       Date:  1996-02       Impact factor: 9.139

6.  The effect of nightly nasal CPAP treatment on underlying obstructive sleep apnea and pharyngeal size.

Authors:  N A Collop; A J Block; D Hellard
Journal:  Chest       Date:  1991-04       Impact factor: 9.410

7.  Effect of short term graded withdrawal of nasal continuous positive airway pressure on systemic blood pressure in patients with obstructive sleep apnoea.

Authors:  J R Stradling; J Partlett; R J Davies; D Siegwart; L Tarassenko
Journal:  Blood Press       Date:  1996-07       Impact factor: 2.835

8.  Magnetic resonance imaging of the upper airway in obstructive sleep apnea before and after chronic nasal continuous positive airway pressure therapy.

Authors:  C F Ryan; A A Lowe; D Li; J A Fleetham
Journal:  Am Rev Respir Dis       Date:  1991-10

Review 9.  Oral appliance treatment for obstructive sleep apnea: an update.

Authors:  Kate Sutherland; Olivier M Vanderveken; Hiroko Tsuda; Marie Marklund; Frederic Gagnadoux; Clete A Kushida; Peter A Cistulli
Journal:  J Clin Sleep Med       Date:  2014-02-15       Impact factor: 4.062

Review 10.  Role of surgery in adult obstructive sleep apnoea.

Authors:  Bhik T Kotecha; Andy C Hall
Journal:  Sleep Med Rev       Date:  2014-02-15       Impact factor: 11.609

View more
  5 in total

1.  Evaluation of Continuous Negative External Pressure (cNEP) for the Treatment of Obstructive Sleep Apnea: A Pilot Study.

Authors:  Jerrold A Kram; Robyn V Woidtke; Kenneth B Klein; Richard M Rose
Journal:  J Clin Sleep Med       Date:  2017-08-15       Impact factor: 4.062

2.  Long-term efficacy of an oral appliance in early treated patients with obstructive sleep apnea.

Authors:  Marie Marklund
Journal:  Sleep Breath       Date:  2015-11-02       Impact factor: 2.816

3.  Comparison of effects of OSA treatment by MAD and by CPAP on cardiac autonomic function during daytime.

Authors:  Martin Glos; Thomas Penzel; Christoph Schoebel; Georg-Reiner Nitzsche; Sandra Zimmermann; Christopher Rudolph; Alexander Blau; Gert Baumann; Paul-Georg Jost-Brinkmann; Stefanie Rautengarten; Jan Christian Meier; Ingrid Peroz; Ingo Fietze
Journal:  Sleep Breath       Date:  2015-10-13       Impact factor: 2.816

Review 4.  Development of a Clinical Pathway and Technical Aspects of Upper Airway Stimulation Therapy for Obstructive Sleep Apnea.

Authors:  Olivier M Vanderveken; Jolien Beyers; Sara Op de Beeck; Marijke Dieltjens; Marc Willemen; Johan A Verbraecken; Wilfried A De Backer; Paul H Van de Heyning
Journal:  Front Neurosci       Date:  2017-09-21       Impact factor: 4.677

5.  The Course of Obstructive Sleep Apnea Syndrome in Patients With Acromegaly During Treatment.

Authors:  Thalijn L C Wolters; Sean H P P Roerink; Linda C A Drenthen; Jolanda H G M van Haren-Willems; Margaretha A E M Wagenmakers; Johannes W A Smit; Adrianus R M M Hermus; Romana T Netea-Maier
Journal:  J Clin Endocrinol Metab       Date:  2020-01-01       Impact factor: 5.958

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.